Clinical Scorecard: Development of a Predictive Model for Depression Risk Among Middle-Aged and Older Adults with Metabolic Syndrome: Utilizing a Nomogram and Interpretable Machine Learning Techniques from CHARLS Data

At a Glance

Key Highlights

• Metabolic syndrome increases risk of depression and mortality when depression coexists.
• Machine learning models can identify complex patterns to predict depression risk in MetS patients.
• CHARLS data provides a large, representative Chinese cohort for model development and validation.

Guideline-Based Recommendations

Diagnosis

• Use CESD-10 scale with a cutoff score ≥10 to identify clinically significant depression.
• Define metabolic syndrome by ATP III criteria including glucose, lipids, blood pressure, and waist circumference.

Management

• Early identification of depression risk in MetS patients to enable personalized interventions.
• Consider integrating machine learning-based predictive tools for clinical decision support.

Monitoring & Follow-up

• Longitudinal follow-up using validated scales like CESD-10 to monitor depressive symptoms.
• Regular assessment of metabolic parameters to manage MetS components.

Risks

• Increased mortality risk when depression coexists with metabolic syndrome.
• Higher depression risk with increasing number of MetS components.

Patient & Prescribing Data

Chinese adults aged 45 and older with metabolic syndrome

Predictive modeling can guide early detection and personalized treatment strategies to reduce depression burden.

Clinical Best Practices

• Screen middle-aged and older adults with MetS for depression using CESD-10.
• Utilize machine learning models to enhance prediction accuracy for depression risk.
• Address modifiable MetS components and psychosocial factors to mitigate depression risk.

References

• Global Burden of Disease Study 2019
• National Cholesterol Education Program Adult Panel III (ATP III) criteria
• China Health and Retirement Longitudinal Study (CHARLS)
• CESD-10 scale validation in Chinese adults